Patents Assigned to REGENESIS SCIENCE CO., LTD.
  • Patent number: 11427808
    Abstract: To provide a method for serum-free culture of human cartilage cells and a serum-free culture medium. A method for serum-free culture of cartilage cells, said method comprising: an enzymatic treatment step for treating a human cartilage cell-containing tissue with a protease; an inhibitor-treatment step for, after the enzymatic treatment step, treating the tissue with an inhibitor for the aforesaid protease; and a culture step for, after the inhibitor-treatment step, culturing the tissue in a serum-free culture medium that contains kartogenin and/or SAG, ITS, FGF2 and hydrocortisone. A serum-free culture medium for culturing cartilage cells, said serum-free culture medium containing kartogenin and/or SAG, ITS, FGF2 and hydrocortisone.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: August 30, 2022
    Assignee: Regenesis Science Co., Ltd.
    Inventors: Hiroko Yanaga, Katsu Yanaga
  • Publication number: 20210363483
    Abstract: [Problem to Be Solved] The present invention is to provide a method of culturing a cell, which method safely increases GDNF mRNA expression without introducing a gene with a virus. [Means to Solve the Problem] A method of producing a cultured cell comprising glial cell line-derived neurotrophic factor (GDNF) mRNA, including the step of culturing a human skin-derived stem cell in a serum-free medium containing at least one of SAG, purmorphamine and sonic hedgehog (SHUT) protein. The medium may further contain B-27 supplement, a ROCK inhibitor, EGF and FGF2.
    Type: Application
    Filed: August 2, 2018
    Publication date: November 25, 2021
    Applicant: REGENESIS SCIENCE CO., LTD.
    Inventors: Hiromichi NISHINA, Hiroko YANAGA